In a recent article, Wu et al.
In a recent article, Wu et al. (1) reported findings from two large-scale, prospective studies in women (Nurses' Health Study) and men (Health Professionals Follow-up Study) showing that higher calcium intake was associated with a statistically significantly reduced risk of distal colon cancer, but not of proximal colon cancer. The authors found a 40%-50% lower risk of distal colon cancer among subjects with a calcium intake of 700-800 mg/day or higher than in subjects with a calcium intake of less than or equal to 500 mg/ day. The authors also cited the results of other studies that indicate a potential protective effect of higher dietary calcium intake, primarily on distal colon cancer. In the United States today, the incidence of colon cancer in the leftsided or distal colon (descending or sigmoid colon, as used by Wu et al.) is about two-thirds of all colon cancers (2). Thus, net total reduction of colon cancer by higher dietary calcium intake as shown in this study can be estimated at approximately 30% (i.e., a 40%-50% reduction of two-thirds of all colon cancer cases).
One possible explanation for the difference in the effect of higher calcium intake on the risk of distal and proximal colon cancer is the variability of pH in different regions of the colon. Probably the most reliable measurements of intraluminal pH were made using a pHsensitive radiotelemetry capsule, which passes freely through the gastrointestinal tract and is monitored for position in the gut of healthy, free-living volunteers (3) . The results of that study showed that the pH of the intestinal contents of the cecum has a mean of 6.4 ± 0.4 (P<.001) and rises progressively from the right (i.e., proximal) colon to the left (i.e., distal) colon to a final mean pH value of 7.0 ± 0.7 (P<.001). This rise in pH increases the ionization of fatty acids and free unconjugated bile acids by approximately fivefold, with accompanying increases in solubility (4,5). Increased ionization and solubilization of long-chain fatty acids and free unconjugated bile acids due to increased pH is deleterious to the colonic mucosa in the rat (4), and the mechanism of this has been discussed (5). Thus, the lower pH of the proximal colon might be expected to aid in the protection of the colon mucosa from fatty acid and bile acid damage by decreasing ionization and solubilization of these lipid acids.
Fatty acids bind to calcium more tightly than to any other component of the normal colon contents (6). Therefore, we suggest that lower dietary intake of calcium, resulting in lower "delivery" of calcium to the distal colon, would result in a larger proportion of tightly bound calcium (primarily to free fatty acids) in the proximal colon. This would result in proportionately less calcium available for binding to fatty acids and bile acids in the distal colon. Increased dietary intake of calcium could prevent this effect by supplying additional calcium to the distal colon, where the concentration of ionized lipids (as free fatty and unconjugated bile acids) increases due to the rise in pH and where they are free to exert their deleterious effect (4,6).
Regardless of the postulated mechanisms, the results of Wu et al.
(1) suggest that an approximately 30% total reduction in colon cancer incidence may be achieved with a moderate increase in dietary calcium intake of 300-400 mg/ day. With colon cancer deaths currently numbering about 55 000 per year in the United States (7), the addition of this amount of dietary calcium intake could effect a reduction of approximately 16 000 colon cancer deaths annually. 
RESPONSE
We thank Drs. Newmark and Shiff for their correspondence. The mechanisms that the authors suggest are interesting and are worth evaluating in future studies. There are a few points, however, that we would like to clarify.
First, the letter states that the "the incidence of colon cancer in the left-sided or distal colon (descending or sigmoid colon, as used by Wu et al.) , is about two-thirds of all colon cancers." According to recently published data (1), the incidence rate of descending and sigmoid cancers combined was approximately 40% of the incidence rate of all colon cancers (excluding rectosigmoid and rectal cancers), although the percentage varies somewhat depending on race, sex, and age group.
Second, the letter states that our results "suggest that an approximately 30% total reduction in colon cancer incidence may be achieved with a moderate increase in dietary calcium intake of 300-400 mg/day." This statement implies that we found a dose-response relationship between dietary calcium intake and risk of colon cancer. However, our results suggest an approximately 40%-50% reduction in distal colon cancer risk with calcium intakes of 700-800 mg/day or more, compared with intakes of less than or equal to 500 mg/day. In addition, calcium intakes above 700-800 mg/day do not seem to be of additional benefit, a finding that is consistent with a possible threshold effect. Based on our results, therefore, only those individuals with calcium intakes below 700-800 mg/day would benefit from additional dietary calcium (2) .
Finally, Newmark and Shiff state that "the addition of this amount of dietary calcium intake could effect a reduction of approximately 16 000 colon cancer deaths annually." This number of colon cancer deaths cannot be derived from our results because we reported only relative risk estimates and not attributable risk estimates for colon cancer incidence. The estimate of 16 000 colon cancer deaths annually assumes that all individuals could potentially benefit from additional calcium, but our results suggest that only those individuals with low calcium intakes would benefit (2) . Nevertheless, although the number of deaths prevented annually may be less than that implied by Newmark and Shiff, we concur that increasing calcium intake for some individuals may have an important role in the prevention of distal colon cancer.
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